Premium
P4‐105: Medical Nutrition in Alzheimer's Disease: The Souvenaid ® Clinical Trial Program
Author(s) -
Kamphuis Patrick J.,
Scheltens Philip,
Hartmann Tobias,
Soininen Hilkka
Publication year - 2010
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2010.08.163
Subject(s) - medicine , dementia , clinical trial , mediterranean diet , randomized controlled trial , cognition , food and drug administration , disease , psychiatry , environmental health
Alcohol never 62 72.7 6 6.6* 33 72.9 6 6.1y before 11 66.3 6 10.8 6 73.3 6 7.6 < 1 drink/month 10 66.4 6 9.2 9 69.7 6 6.9 > 1 drink/day 4 71.3 6 6.0 2 73.0 6 0.0 Smoking never 60 71.2 6 7.2y 29 72.5 6 6.5y before 13 74.5 6 3.5 9 73.4 6 8.1 < 1 pk/day 14 67.8 6 12.0 11 71.1 6 4.6 > 1.5 pk/day 1 73.0 6 Family history of Dementia no 75 72.0 6 7.3y 42 72.4 6 6.5y yes 12 65.3 6 9.3 8 71.9 6 5.5 Family history of Stroke no 70 72.0 6 7.5z 35 72.8 6 6.7y yes 17 67.4 6 8.4 15 71.2 6 5.2 Personal history of Stroke no 74 70.9 6 7.9y 29 72.6 6 5.6y yes 13 72.6 6 8.0 21 72.1 6 7.3 Personal history of HTN no 52 70.7 6 7.8y 22 75.0 6 6.2z yes 35 71.7 6 8.2 28 70.3 6 5.7 Personal history of DM no 63 70.3 6 7.9y 31 72.7 6 6.5y yes 24 73.3 6 7.7 19 71.7 6 6.0 Personal history of CHD no 77 70.5 6 8.0z 45 72.6 6 6.1y yes 10 76.2 6 4.8 5 70.4 6 8.8 Personal history of Hyperlipidemia no 63 71.2 6 7.8y 33 72.6 6 6.4y epsilon 4 carreir Status epsilon 4<1 Control group Control group epsilon 4 1 4.145 2.010